loader
Please Wait
Applying Filters...
menu
    • menu

    Quality Alerts: Taro Pharmaceuticals U.S.A., Inc. Issues Voluntary Nationwide Recall of Lamotrigine Tablets - Taro Pharmaceutical Industries

    MenuTaro Pharmaceutical Industries

    Uploaded: 2018
    News
    Taro's Generic PEG-3350 Receives Approval in US

    28 Jun 2024

    // FDA

    Sun Pharma Completes Taro Merger

    24 Jun 2024

    // PR NEWSWIRE

    Taro's Generic Diclofenac Potassium Receives Approval in US

    14 Jun 2024

    // FDA

    DATA COMPILATION
    #PharmaFlow

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Contact Supplier

    BMWS24

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
    Xls

    CATEGORY PAGE
    Menu

    Taro Pharmaceutical Industries

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    PC100901